C4 Therapeutics, Inc. is an innovative biopharmaceutical firm based in Watertown, Massachusetts, specializing in the development of new therapeutic candidates that specifically target and eliminate disease-causing proteins. With a strong focus on oncology and neurodegenerative disorders, the company's proprietary dynamic protein degradation platform leverages advanced biological mechanisms to offer transformative treatment options for patients with unmet medical needs. C4 Therapeutics is positioned at the forefront of the biopharmaceutical landscape, aiming to improve patient outcomes through groundbreaking therapies.
Click "Analyze" to generate stock analysis
CCCC Price Trend and Signals
CCCC Option Volumes & Open Interests (aggregated)
CCCC Put Call Ratios and IV (aggregated)
CCCC Financials
2025-10-27Somewhat Bullishprice_signal
Monthly high detected.
2025-10-16Bullishmacd_signal
Golden cross below zero detected.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.